AbbVie Inc. (ABBV)
AbbVie Inc. Return on Capital Employed (ROCE)
| Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Capital Employed (ROCE) | 0.0% | 23.4% | 21.8% | 36.5% | 21.0% | 14.7% | 20.7% | 15.0% | 12.9% | 12.2% | 21.5% | 10.4% | 14.1% | 14.9% | 11.0% |
AbbVie Inc. (ABBV) Return on Capital Employed (ROCE) comparison analysis
ABBV key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
FAQ
1) What is AbbVie Inc.'s Return on Capital Employed (ROCE)?
As of today, Microsoft Corp's last 12-month Return on Capital Employed (ROCE) is 9.9%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Return on Capital Employed (ROCE) for AbbVie Inc. have been 12.9% over the past three years, and 13.4% over the past five years.
2) Is AbbVie Inc.'s Return on Capital Employed (ROCE) Good?
As of today, AbbVie Inc.'s Return on Capital Employed (ROCE) is 9.9%, which is lower than industry median of 11.7%. It indicates that AbbVie Inc.'s Return on Capital Employed (ROCE) is Bad.